To dissect the mechanisms underlying AR’s promotion of RCC cell proliferation, we focused on the ASS1, as recent studies have indicated that decreased ASS1 activity might lead to an increase in the tumor growth6,7. This evidence concerns the gene ASS1 and renal cell carcinoma.